Trump administration reportedly shortlisting CDC nominees
Source: SeekingAlpha
2026-03-21 12:24:28 ET
More on Pfizer, Moderna, etc.
- Pfizer: I'm Still Expecting A Massive Rebound
- Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation
- Pfizer: Cheap For A Reason
- Pfizer tells shareholders to reject mini-tender offer
- Pfizer posts late-stage trial win for Talzenna plus Xtandi in new prostate cancer indication
Read the full article on Seeking Alpha
For further details see:
Trump administration reportedly shortlisting CDC nominees
Sanofi
NASDAQ: SNYNF
SNYNF Trading
0.01% G/L:
$93.85 Last:
2,501 Volume:
$93.85 Open:
SNYNF Latest News
April 07, 2026 01:00:00 am
Press Release: Sanofi's lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
March 31, 2026 01:00:00 am
Press Release: Sanofi's Rezurock approved in the EU to treat chronic graft-vs-host disease
SNYNF Stock Data
$121,583,170,304
1,228,540,835
N/A
1460
N/A
Pharmaceuticals
Healthcare
FR
Paris
